Placebo enema
Sponsors
PurGenesis Technologies Inc., Hamilton Health Sciences Corporation, Ferring Pharmaceuticals, Rhonda Brand, University of British Columbia
Conditions
Clostridioides Difficile InfectionHIV PreventionInflammatory Bowel DiseasesLeft-Sided Ulcerative ColitisProctosigmoiditisUlcerative Colitis
Phase 1
Phase 2
Safety, Tolerability, Efficacy Study of PUR 0110 Rectal Enema in Mild-to-Moderate Distal Ulcerative Colitis
CompletedNCT01149707
Start: 2010-06-01End: 2015-06-20Updated: 2018-05-01
Fecal Biotherapy for the Induction of Remission in Active Ulcerative Colitis
CompletedNCT01545908
Start: 2012-03-31End: 2014-08-31Target: 130Updated: 2015-03-19
FMT for Remission of Active Ulcerative Colitis in Adults
WithdrawnNCT04202211
Start: 2022-03-31End: 2028-12-31Updated: 2023-05-10